Allianz Euroland Equity Growth PT H2 CHF

Performance History31/03/2024
Growth of 1,000 (EUR)
Allianz Euroland Equity Growth PT H2 CHF
Fund12.826.3-28.623.85.3
+/-Cat-----
+/-Idx-----
 
Key Stats
NAV
23/04/2024
 CHF 1417.39
Day Change -
Morningstar Category™ Other Equity
ISIN LU1228143431
Fund Size (Mil)
23/04/2024
 EUR 528.21
Share Class Size (Mil)
23/04/2024
 CHF 0.06
Max Initial Charge -
Ongoing Charge
16/02/2024
  1.00%
Investment Objective: Allianz Euroland Equity Growth PT H2 CHF
Long-term capital growth by investing in Eurozone equity markets with a focus on growth stocks.
Returns
Trailing Returns (EUR)23/04/2024
YTD-
3 Years Annualised-
5 Years Annualised-
10 Years Annualised-
12 Month Yield 0.00
Management
Manager Name
Start Date
Andreas Hildebrand
01/06/2017
Giovanni Trombello
10/10/2023
Inception Date
01/06/2015
Advertisement
Benchmarks
Fund BenchmarkMorningstar Benchmark
S&P Eurozone LargeMid Growth TR USD-
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNot Specific
GrowthYes
IncomeYes
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  Allianz Euroland Equity Growth PT H2 CHF31/03/2024
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks100.090.00100.09
Bonds0.000.000.00
Cash0.430.52-0.09
Other0.000.000.00
Top 5 Regions%
Eurozone100.00
United States0.00
Canada0.00
Latin America0.00
United Kingdom0.00
Top 5 Sectors%
Technology31.58
Consumer Cyclical26.32
Healthcare12.28
Industrials11.62
Consumer Defensive7.34
Top 5 HoldingsSector%
ASML Holding NVTechnologyTechnology9.29
Lvmh Moet Hennessy Louis Vuitton SEConsumer CyclicalConsumer Cyclical8.31
Hermes International SAConsumer CyclicalConsumer Cyclical6.65
L'Oreal SAConsumer DefensiveConsumer Defensive4.92
Kingspan Group PLCIndustrialsIndustrials4.86
Allianz Euroland Equity Growth PT H2 CHF

Related

In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookie Settings        Disclosures